Integra LifeSciences Holdings Corporation (IART)
USD 20.06
(-7.9%)
USD 20.06
(-7.9%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 111.52 Million USD | -27.14% |
| 2022 | 238.92 Million USD | 21.14% |
| 2021 | 197.23 Million USD | 30.3% |
| 2020 | 151.37 Million USD | -15.42% |
| 2019 | 178.97 Million USD | 61.24% |
| 2018 | 110.99 Million USD | 147.74% |
| 2017 | 44.8 Million USD | -61.15% |
| 2016 | 115.34 Million USD | 44.92% |
| 2015 | 79.58 Million USD | 21.43% |
| 2014 | 65.54 Million USD | 1898.6% |
| 2013 | -3.64 Million USD | -104.94% |
| 2012 | 73.78 Million USD | 34.36% |
| 2011 | 54.91 Million USD | -44.36% |
| 2010 | 98.69 Million USD | 0.89% |
| 2009 | 97.82 Million USD | 106.33% |
| 2008 | 47.41 Million USD | -29.54% |
| 2007 | 67.28 Million USD | 14.54% |
| 2006 | 58.74 Million USD | 4.7% |
| 2005 | 56.1 Million USD | 126.42% |
| 2004 | 24.77 Million USD | -37.5% |
| 2003 | 39.64 Million USD | 106.63% |
| 2002 | 19.18 Million USD | 34.31% |
| 2001 | 14.28 Million USD | 177.71% |
| 2000 | -18.38 Million USD | -48.25% |
| 1999 | -12.4 Million USD | 12.06% |
| 1998 | -14.1 Million USD | 25.79% |
| 1997 | -19 Million USD | -100.0% |
| 1996 | -9.5 Million USD | -58.33% |
| 1995 | -6 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -8.15 Million USD | -123.12% |
| 2024 Q1 | 3.96 Million USD | -92.91% |
| 2024 Q2 | 35.25 Million USD | 789.35% |
| 2023 Q4 | 55.88 Million USD | 110.13% |
| 2023 Q1 | 36.38 Million USD | -46.37% |
| 2023 FY | 174.07 Million USD | -27.14% |
| 2023 Q3 | 26.59 Million USD | 112.68% |
| 2023 Q2 | 12.5 Million USD | -65.63% |
| 2022 FY | 238.92 Million USD | 21.14% |
| 2022 Q3 | 65.04 Million USD | 8.66% |
| 2022 Q4 | 67.84 Million USD | 4.29% |
| 2022 Q2 | 59.86 Million USD | 29.68% |
| 2022 Q1 | 46.16 Million USD | -20.71% |
| 2021 Q1 | 30.71 Million USD | -41.66% |
| 2021 Q3 | 56.43 Million USD | 8.84% |
| 2021 Q4 | 58.22 Million USD | 3.16% |
| 2021 FY | 197.23 Million USD | 30.3% |
| 2021 Q2 | 51.85 Million USD | 68.83% |
| 2020 Q1 | 27.1 Million USD | -24.88% |
| 2020 Q3 | 57.54 Million USD | 308.68% |
| 2020 Q4 | 52.64 Million USD | -8.51% |
| 2020 FY | 151.37 Million USD | -15.42% |
| 2020 Q2 | 14.08 Million USD | -48.05% |
| 2019 Q2 | 45.95 Million USD | 42.25% |
| 2019 Q3 | -20.58 Million USD | -144.79% |
| 2019 Q4 | 36.08 Million USD | 275.26% |
| 2019 FY | 178.97 Million USD | 61.24% |
| 2019 Q1 | 32.3 Million USD | -5.28% |
| 2018 Q4 | 34.1 Million USD | 44.06% |
| 2018 Q2 | 27.63 Million USD | 8.03% |
| 2018 Q1 | 25.57 Million USD | 254.38% |
| 2018 FY | 110.99 Million USD | 147.74% |
| 2018 Q3 | 23.67 Million USD | -14.32% |
| 2017 Q2 | 16.98 Million USD | 70.55% |
| 2017 Q3 | 10.64 Million USD | -37.34% |
| 2017 Q4 | 7.21 Million USD | -32.17% |
| 2017 FY | 44.8 Million USD | -61.15% |
| 2017 Q1 | 9.95 Million USD | -75.57% |
| 2016 Q3 | 30.09 Million USD | 34.49% |
| 2016 Q4 | 40.76 Million USD | 35.47% |
| 2016 FY | 115.34 Million USD | 44.92% |
| 2016 Q2 | 22.37 Million USD | 1.17% |
| 2016 Q1 | 22.11 Million USD | -7.87% |
| 2015 Q4 | 24 Million USD | 140.22% |
| 2015 Q1 | 16.78 Million USD | -37.09% |
| 2015 Q2 | 13.95 Million USD | -16.88% |
| 2015 Q3 | 9.99 Million USD | -28.38% |
| 2015 FY | 79.58 Million USD | 21.43% |
| 2014 Q4 | 26.68 Million USD | 50.53% |
| 2014 Q3 | 17.72 Million USD | 43.05% |
| 2014 FY | 65.54 Million USD | 1898.6% |
| 2014 Q1 | 8.73 Million USD | -51.55% |
| 2014 Q2 | 12.39 Million USD | 41.82% |
| 2013 Q2 | 7.97 Million USD | 18231.82% |
| 2013 Q4 | 18.03 Million USD | 160.9% |
| 2013 FY | -3.64 Million USD | -104.94% |
| 2013 Q1 | -44 Thousand USD | -100.24% |
| 2013 Q3 | -29.61 Million USD | -471.2% |
| 2012 Q2 | 18.02 Million USD | 3.17% |
| 2012 Q3 | 19.73 Million USD | 9.52% |
| 2012 Q4 | 18.55 Million USD | -5.97% |
| 2012 FY | 73.78 Million USD | 34.36% |
| 2012 Q1 | 17.46 Million USD | 125.41% |
| 2011 Q3 | 18.29 Million USD | 128.64% |
| 2011 Q1 | 20.87 Million USD | -13.62% |
| 2011 Q2 | 8 Million USD | -61.67% |
| 2011 Q4 | 7.74 Million USD | -57.63% |
| 2011 FY | 54.91 Million USD | -44.36% |
| 2010 Q3 | 27.3 Million USD | 11.11% |
| 2010 Q1 | 22.64 Million USD | -18.69% |
| 2010 FY | 98.69 Million USD | 0.89% |
| 2010 Q4 | 24.16 Million USD | -11.52% |
| 2010 Q2 | 24.57 Million USD | 8.55% |
| 2009 Q4 | 27.84 Million USD | 16.91% |
| 2009 Q1 | 22.25 Million USD | -10.88% |
| 2009 Q2 | 23.9 Million USD | 7.43% |
| 2009 FY | 97.82 Million USD | 106.33% |
| 2009 Q3 | 23.82 Million USD | -0.36% |
| 2008 Q4 | 24.96 Million USD | 209.07% |
| 2008 FY | 47.41 Million USD | -29.54% |
| 2008 Q3 | -22.89 Million USD | -192.31% |
| 2008 Q2 | 24.79 Million USD | 20.75% |
| 2008 Q1 | 20.53 Million USD | 32.03% |
| 2007 FY | 67.28 Million USD | 14.54% |
| 2007 Q4 | 15.55 Million USD | -15.17% |
| 2007 Q3 | 18.33 Million USD | 8.53% |
| 2007 Q1 | 16.5 Million USD | -18.09% |
| 2007 Q2 | 16.89 Million USD | 2.38% |
| 2006 Q2 | 13.15 Million USD | -3.42% |
| 2006 Q3 | 11.81 Million USD | -10.21% |
| 2006 Q4 | 20.14 Million USD | 70.54% |
| 2006 FY | 58.74 Million USD | 4.7% |
| 2006 Q1 | 13.62 Million USD | -8.64% |
| 2005 FY | 56.1 Million USD | 126.42% |
| 2005 Q4 | 14.91 Million USD | -7.32% |
| 2005 Q1 | 12.95 Million USD | -4.95% |
| 2005 Q2 | 12.14 Million USD | -6.28% |
| 2005 Q3 | 16.09 Million USD | 32.51% |
| 2004 Q1 | 11.72 Million USD | -9.75% |
| 2004 Q4 | 13.63 Million USD | 211.91% |
| 2004 Q3 | -12.18 Million USD | -205.0% |
| 2004 Q2 | 11.6 Million USD | -1.1% |
| 2004 FY | 24.77 Million USD | -37.5% |
| 2003 Q1 | 7.44 Million USD | 9.73% |
| 2003 FY | 39.64 Million USD | 106.63% |
| 2003 Q4 | 12.99 Million USD | 18.99% |
| 2003 Q3 | 10.92 Million USD | 31.76% |
| 2003 Q2 | 8.28 Million USD | 11.41% |
| 2002 Q4 | 6.78 Million USD | 325.88% |
| 2002 FY | 19.18 Million USD | 34.31% |
| 2002 Q1 | 5.32 Million USD | 13.01% |
| 2002 Q2 | 5.49 Million USD | 3.1% |
| 2002 Q3 | 1.59 Million USD | -71.0% |
| 2001 FY | 14.28 Million USD | 177.71% |
| 2001 Q2 | 3.45 Million USD | 45.09% |
| 2001 Q3 | 3.73 Million USD | 8.1% |
| 2001 Q4 | 4.71 Million USD | 26.12% |
| 2001 Q1 | 2.38 Million USD | 117.77% |
| 2000 Q1 | -2.42 Million USD | -86.23% |
| 2000 Q3 | -713 Thousand USD | 61.4% |
| 2000 Q4 | -13.4 Million USD | -1779.66% |
| 2000 FY | -18.38 Million USD | -48.25% |
| 2000 Q2 | -1.84 Million USD | 23.71% |
| 1999 Q1 | -3.5 Million USD | -9.38% |
| 1999 Q3 | -2.7 Million USD | 43.75% |
| 1999 Q4 | -1.3 Million USD | 51.85% |
| 1999 FY | -12.4 Million USD | 12.06% |
| 1999 Q2 | -4.8 Million USD | -37.14% |
| 1998 FY | -14.1 Million USD | 25.79% |
| 1998 Q3 | -3.2 Million USD | 23.81% |
| 1998 Q4 | -3.2 Million USD | 0.0% |
| 1998 Q1 | -3.6 Million USD | 67.57% |
| 1998 Q2 | -4.2 Million USD | -16.67% |
| 1997 Q2 | -2.6 Million USD | -13.04% |
| 1997 FY | -19 Million USD | -100.0% |
| 1997 Q4 | -11.1 Million USD | -282.76% |
| 1997 Q3 | -2.9 Million USD | -11.54% |
| 1997 Q1 | -2.3 Million USD | 11.54% |
| 1996 FY | -9.5 Million USD | -58.33% |
| 1996 Q1 | -1.9 Million USD | 17.39% |
| 1996 Q2 | -2.1 Million USD | -10.53% |
| 1996 Q3 | -2.6 Million USD | -23.81% |
| 1996 Q4 | -2.6 Million USD | 0.0% |
| 1995 Q4 | -2.3 Million USD | -64.29% |
| 1995 FY | -6 Million USD | 0.0% |
| 1995 Q3 | -1.4 Million USD | -160.87% |
| 1995 Q2 | 2.3 Million USD | 0.0% |
| 1995 Q1 | 2.3 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 876.589% |
| Cerus Corporation | -30.05 Million USD | 471.098% |
| OrthoPediatrics Corp. | -25.76 Million USD | 532.842% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 1150.018% |
| Talis Biomedical Corporation | -66.81 Million USD | 266.918% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 744.808% |
| Inogen, Inc. | -109.38 Million USD | 201.956% |
| Spectral AI, Inc. | -12.98 Million USD | 958.949% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 278.188% |
| CVRx, Inc. | -43.1 Million USD | 358.743% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 3261.168% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 997.377% |
| Orthofix Medical Inc. | -139.11 Million USD | 180.171% |
| Venus Concept Inc. | -28.3 Million USD | 493.96% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 306.423% |
| Bioventus Inc. | -81.72 Million USD | 236.465% |
| BrainsWay Ltd. | -4.92 Million USD | 2363.568% |
| Envoy Medical, Inc. | -18.37 Million USD | 707.076% |
| electroCore, Inc. | -18.8 Million USD | 693.066% |
| IceCure Medical Ltd | -15.57 Million USD | 816.012% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 330.036% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 745.853% |
| MaxCyte, Inc. | -48.29 Million USD | 330.907% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 1032.862% |
| Nexalin Technology, Inc. | -5.69 Million USD | 2057.869% |
| PAVmed Inc | -68.79 Million USD | 262.114% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 297.171% |
| RxSight, Inc. | -50.08 Million USD | 322.673% |
| Sight Sciences, Inc. | -57.27 Million USD | 294.724% |
| SI-BONE, Inc. | -46.93 Million USD | 337.638% |
| TELA Bio, Inc. | -44.07 Million USD | 353.037% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 305.958% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 316.859% |
| LivaNova PLC | -68.49 Million USD | 262.816% |
| 908 Devices Inc. | -42.75 Million USD | 360.831% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 164.319% |
| Nemaura Medical Inc. | -9.59 Million USD | 1262.306% |
| NeuroPace, Inc. | -27.17 Million USD | 510.414% |
| LENSAR, Inc. | -12.22 Million USD | 1011.98% |
| Apyx Medical Corporation | -17.25 Million USD | 746.19% |
| Cutera, Inc. | -156.23 Million USD | 171.386% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 1396.211% |
| BioSig Technologies, Inc. | -28.51 Million USD | 491.155% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 227.256% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 596.864% |
| Axonics, Inc. | -26.05 Million USD | 528.008% |
| Outset Medical, Inc. | -169.77 Million USD | 165.692% |
| IRIDEX Corporation | -10 Million USD | 1214.48% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 202.158% |
| IRadimed Corporation | 20.03 Million USD | -456.643% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 1452.65% |
| INVO Bioscience, Inc. | -6.76 Million USD | 1748.049% |
| Telesis Bio, Inc. | -35.15 Million USD | 417.286% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -678.269% |
| Varex Imaging Corporation | 32.1 Million USD | -247.433% |
| Quipt Home Medical Corp. | 3.91 Million USD | -2745.777% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1019.196% |
| Pulmonx Corporation | -61.93 Million USD | 280.069% |
| Dynatronics Corporation | -2.27 Million USD | 5006.452% |
| Modular Medical, Inc. | -17.52 Million USD | 736.237% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 861.842% |
| Semler Scientific, Inc. | 22.25 Million USD | -401.105% |
| InMode Ltd. | 195.66 Million USD | 43.0% |
| Bruker Corporation | 436.9 Million USD | 74.473% |
| Cytosorbents Corporation | -31.2 Million USD | 457.349% |
| DexCom, Inc. | 597.7 Million USD | 81.341% |
| Align Technology, Inc. | 643.33 Million USD | 82.664% |
| Viveve Medical, Inc. | -21.55 Million USD | 617.45% |
| ZimVie Inc. | -30.93 Million USD | 460.471% |
| Movano Inc. | -29.69 Million USD | 475.635% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 500.524% |
| Nexalin Technology, Inc. | -5.69 Million USD | 2057.869% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 3261.168% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 147.818% |
| Profound Medical Corp. | -28.61 Million USD | 489.733% |
| Insulet Corporation | 220 Million USD | 49.306% |
| enVVeno Medical Corporation | -25.23 Million USD | 541.897% |
| Surmodics, Inc. | -5.64 Million USD | 2075.66% |
| iCAD, Inc. | -7.68 Million USD | 1550.462% |
| Nuwellis, Inc. | -17.63 Million USD | 732.592% |
| Biotricity, Inc. | -8.82 Million USD | 1363.283% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 189.106% |
| Aethlon Medical, Inc. | -12.63 Million USD | 982.566% |
| InspireMD, Inc. | -21.14 Million USD | 627.484% |
| PAVmed Inc. | -68.79 Million USD | 262.114% |
| BIOLASE, Inc. | -17.93 Million USD | 721.765% |
| Beyond Air, Inc. | -63 Million USD | 277.009% |
| FONAR Corporation | 16.53 Million USD | -574.47% |
| AxoGen, Inc. | -21.46 Million USD | 619.644% |
| Vivani Medical, Inc. | -26.96 Million USD | 513.595% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -518.181% |
| Inari Medical, Inc. | -14.03 Million USD | 894.798% |
| UFP Technologies, Inc. | 57.66 Million USD | -93.407% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 2363.292% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 1868.634% |
| Tenon Medical, Inc. | -15.72 Million USD | 809.137% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 1592.186% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 361.147% |
| AdaptHealth Corp. | -598.4 Million USD | 118.637% |
| Sintx Technologies, Inc. | -13.35 Million USD | 934.9% |
| NanoVibronix, Inc. | -3.43 Million USD | 3345.809% |
| Quanterix Corporation | -49.7 Million USD | 324.394% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1019.196% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 29295.288% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 133.344% |
| TransMedics Group, Inc. | -28.72 Million USD | 488.227% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 572.328% |
| NeuroMetrix, Inc. | -7.15 Million USD | 1659.472% |
| Hyperfine, Inc. | -48.11 Million USD | 331.791% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 271.51% |
| Biomerica, Inc. | -6.36 Million USD | 1851.626% |
| Bone Biologics Corporation | -9.42 Million USD | 1282.885% |
| AVITA Medical, Inc. | -40.4 Million USD | 376.04% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 1181.599% |
| Silk Road Medical, Inc | -59.27 Million USD | 288.163% |